{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-015647","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2025-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.759580+00:00","generated_at":"2026-05-26T09:13:47.074610+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"HOOKIPA abandons plan to acquire Poolbeg Pharma; issues Rule 2.8 no-offer statement","bullets":["HOOKIPA board decides not to proceed with all-share acquisition of Poolbeg Pharma announced on Jan 2, 2025.","Announcement made under UK Takeover Code Rule 2.8; HOOKIPA reserves right to reverse under certain conditions.","Discussions for combination have ceased; no firm offer was made.","Financial adviser Moelis & Company advised HOOKIPA on the potential deal."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-015647","json":"https://secwatch.observer/filing/0001104659-25-015647.json","markdown":"https://secwatch.observer/filing/0001104659-25-015647.md","text":"https://secwatch.observer/filing/0001104659-25-015647.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000110465925015647/0001104659-25-015647-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000110465925015647/tm257203d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T09:13:47.074610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}